SUPREME COURT REVIEW OF VACCINE INJURY TRUST FUND CASE
SUPREME COURT REVIEW OF VACCINE INJURY TRUST FUND CASE will likely focus on the extent to which pre-existing conditions are to be considered in determining whether a child has been injured by administration of a covered vaccine. On Oct. 31, the Supreme Court granted a writ of certiorari to accept Shalala v. Whitecotton and review a February ruling by the D.C. circuit Court ordering HHS to pay compensation to Margaret Whitecotton for a claim of encephalopathy following administration of a diphtheria-pertussis- tetanus booster in 1975.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth